Glial Cell Line Derived Neurotrophic Factor Market to Signify Strong Growth by 2023-2029
Glial cell line derived neurotrophic factor market is anticipated to grow at a significant CAGR during the forecast period. Glial cell-derived neurotrophic factor (GDNF) is a protein encoded in humans by the GDNF gene. GDNF is a small protein that promotes the survival of several different types of neurons and communicates through GFR receptors, particularly GFR1. The major factor contributing to the growth of the market is the increasing prevalence of Parkinson’s disease (PD) across the globe.
According to the Parkinson
Foundation, almost one million people are living with PD in the US which is
expected to rise to 1.2 million in 2030. Additionally, approximately 60,000
Americans are diagnosed with PD each year and more than 10 million people are
living with Parkinson's disease globally. Further, Parkinson disease increases
with age however, an estimated 4% of people with Parkinson disease are
diagnosed before age 50. Moreover, the prevalence of Parkinson’s disease in men
are 1.5 times as compared to women. Hence, the increasing prevalence of this
disease is increasing the demand for glial cell line derived neurotrophic
factors for treatment, which in turn, is driving the growth of the global glial
cell line derived neurotrophic factor market. Some major players in the market
include GlaxoSmithKline plc and Treeway BV, among others. The market players
are contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical expansion,
partnerships and collaborations, and new product launches, to stay competitive
in the market.
To Request a Sample of our Report on Glial Cell Line
Derived Neurotrophic Factor Market: https://www.omrglobal.com/request-sample/glial-cell-line-derived-neurotrophic-factor-market
Market Coverage
• The market number available for – 2021-2030
• Base year- 2022
• Forecast period- 2023-2030
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
GlaxoSmithKline Plc, and Treeway BV, among others
Glial Cell Line Derived Neurotrophic Factor Market Report
by Segment
By Type
• GSK-812
• LAUR-301
• TW-002
• AMT-090
• Others
By Application
• Amyotrophic Lateral Sclerosis
• Brain Ischemia
• Parkinson’s Disease
• Retinal Degeneration
• Others
A
full Report of Glial Cell Line Derived Neurotrophic Factor Market is Available
@ https://www.omrglobal.com/industry-reports/glial-cell-line-derived-neurotrophic-factor-market
Glial Cell Line Derived Neurotrophic Factor Market Report
by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/glial-cell-line-derived-neurotrophic-factor-market
About Orion Market Research
Orion Market Research (OMR) is a
market research and consulting company known for its crisp and concise reports.
The company is equipped with an experienced team of analysts and consultants.
OMR offers quality syndicated research reports, customized research reports,
consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto
Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment